Recent News & Events

Chimeron Bio Appoints Antonin de Fougerolles to its Board of Directors
Press Releases

Chimeron Bio Appoints Antonin de Fougerolles to its Board of Directors

Philadelphia, PA – Chimeron Bio, an RNA company developing self-amplifying RNA (saRNA) vaccines and therapeutics designed on its proprietary ChaESAR™…

300 300 Chimeron Bio | Advancing Genetic Medicine
Chimeron Bio Welcomes Kevin Heyeck as New CEO
Press Releases

Chimeron Bio Welcomes Kevin Heyeck as New CEO

Philadelphia, PA – Chimeron Bio, an RNA company developing self-amplifying RNA (saRNA) vaccines and therapeutics designed on its proprietary ChaESAR™…

300 300 Chimeron Bio | Advancing Genetic Medicine
Chimeron Bio Enters Into Manufacturing Agreement With FUJIFILM Diosynth Biotechnologies to Advance its RNA Oncology Candidates
Press Releases

Chimeron Bio Enters Into Manufacturing Agreement With FUJIFILM Diosynth Biotechnologies to Advance its RNA Oncology Candidates

Philadelphia, PA and College Station, TX – Chimeron Bio, an RNA company developing self-amplifying RNA (saRNA) vaccines and therapeutics designed…

206 206 Chimeron Bio | Advancing Genetic Medicine
Chimeron Bio Enters Into an Agreement with the NIAID, a Federal Agency, for Pre-clinical Assessment of its Self-Amplifying COVID-19 Vaccine
Press Releases

Chimeron Bio Enters Into an Agreement with the NIAID, a Federal Agency, for Pre-clinical Assessment of its Self-Amplifying COVID-19 Vaccine

Philadelphia, PA – Chimeron Bio, an RNA company developing self-amplifying RNA (saRNA) vaccines and therapeutics designed on its proprietary ChaESARTM…

300 300 Chimeron Bio | Advancing Genetic Medicine
Chimeron Bio Expands Footprint in Philadelphia by Joining BioLabs at The Curtis
Press Releases

Chimeron Bio Expands Footprint in Philadelphia by Joining BioLabs at The Curtis

Philadelphia, PA – Chimeron Bio, a biotechnology company pioneering a novel class of self-amplifying RNA-vaccines and therapeutics announced its plan…

625 625 Chimeron Bio | Advancing Genetic Medicine
Close